Counselors in Hanover, VA Accepting Medicare
3 Counselors found. Showing 1 - 3
 Dr. Stephen R Adams, PHD, LPC, CRC Counselor - Professional Medicare: Not Enrolled in Medicare Practice Location: 10515 Cabaniss Ln, Hanover, VA 23069 Phone: 804-559-9959 Fax: 804-559-9613 |
Mr. Todd Charles Stonnell, LPC, ATR-BC Counselor - Mental Health Medicare: Not Enrolled in Medicare Practice Location: 10515 Cabaniss Ln, Hanover, VA 23069 Phone: 804-559-9959 |
 Marlene Joan Adams Counselor Medicare: Medicare Enrolled Practice Location: 7240 Courtland Farm Rd, Hanover, VA 23069 Phone: 804-365-6400 |
News Archive
HIV-positive women who were sexually abused as children benefit from intervention program
A UCLA-led study of HIV-positive women who were sexually abused as children has found that the more severe their past trauma, the greater their improvement in an intervention program designed to ease their psychological suffering.
AVEO achieves enrollment target for tivozanib global Phase 3 clinical trial in advanced renal cell carcinoma
AVEO Pharmaceuticals, Inc., a biopharmaceutical company focused on discovering, developing and commercializing cancer therapeutics, today announced that it has achieved its enrollment target for TIVO-1, its global Phase 3 clinical trial for its oral, triple VEGF receptor inhibitor, tivozanib, in patients with advanced renal cell carcinoma. In February of this year, AVEO initiated enrollment in TIVO-1, and has successfully reached the target enrollment of 500 patients.
Aduro raises $19.25 million through Series B equity financing
Aduro BioTech, a clinical-stage immunotherapy company, announced today that it has completed its Series B equity financing from a combination of current investors and Morningside Ventures, bringing the total capital secured in this round to $19.25 million. In addition, Ms. Stephanie O'Brien, who represents Morningside, has joined Aduro's Board of Directors.
Medicago announces official groundbreaking ceremony for U.S. plant-based commercial grade vaccine facility
Medicago U.S.A. Inc., a wholly owned subsidiary of Medicago Inc., a biotechnology company focused on developing highly effective and affordable vaccines based on proprietary manufacturing technologies and Virus-Like Particles (VLPs), today announced that company executives, along with U.S. Senator Kay Hagan (D-NC) and U.S. Congressman David Price (D-NC), are holding an official groundbreaking ceremony this morning for its U.S. plant-based commercial grade vaccine facility in Research Triangle Park, North Carolina.
› Verified 2 days ago